CV6 Therapeutics founder and CEO Dr. Robert Ladner joins Dr. Moira Gunn on BioTech Nation to discuss the company’s work to improve the effectiveness of established cancer chemotherapy.
In this September 2023 interview, the conversation explores CV6’s approach to building on existing treatments, with an initial development focus on colorectal and gastrointestinal cancers.
BioTech Nation | September 27, 2023 | 20 minutes, 31 seconds
The focus of the world was on Belfast as global political leader’s past, and present arrived in Belfast to mark the 25th anniversary of the Belfast/Good Friday Agreement.
New all-island research led by Queen’s University Belfast highlights the health and economic impact of the Good Friday Agreement on cancer across the island of Ireland in the last 25 years.